UPDATE: MLV & Co Initiates Coverage On Flexion Therapeutics On Multiple Positive Factors

By: via Benzinga
In a report published Tuesday, MLV & Co analyst Ken Trbovich initiated coverage on Flexion Therapeutics, Inc. (NASDAQ: FLXN) with a Buy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.